Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LENSAR, Inc. (LNSR : NSDQ)

• Company Description    LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida. Number of Employees: 150

• Price / Volume Information    Yesterday's Closing Price: $6.07 Daily Weekly Monthly 20 Day Moving Average: 46,155 shares Shares Outstanding: 12.29 (millions) Market Capitalization: $74.58 (millions) Beta: 0.95 52 Week High: $12.94 52 Week Low: $4.95 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -14.21% -13.30% 12 Week 17.41% 14.54% Year To Date -47.81% -53.76%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2800 Discovery Drive - Orlando,FL 32826 USA ph: 888-536-7271 fax: - ir.contact@lensar.com http://www.lensar.com

• General Corporate Information    Officers Nicholas T. Curtis - Chief Executive Officer and Director William J. Link - Chairperson of the Board of Directors Thomas R. Staab, II - Chief Financial Officer Todd B. Hammer - Director Elizabeth G. O'Farrell - Director Peer Information LENSAR, Inc. (ABMD) LENSAR, Inc. (DMDS) LENSAR, Inc. (CPWY.) LENSAR, Inc. (EQUR) LENSAR, Inc. (ECIA) LENSAR, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 52634L108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/05/26 Share - Related Items Shares Outstanding: 12.29 Most Recent Split Date: (:1) Beta: 0.95 Market Capitalization: $74.58 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.00 Price/Cash Flow: - Price / Sales: 1.24 EPS Growth vs. Year Ago Period: 166.67% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 18.37% vs. Previous Quarter: 22.84% ROE 09/30/26 - - 06/30/26 - -529.08 03/31/26 - -183.19 ROA 09/30/26 - - 06/30/26 - 50.03 03/31/26 - 42.26 Current Ratio 09/30/26 - - 06/30/26 - 2.39 03/31/26 - 2.38 Quick Ratio 09/30/26 - - 06/30/26 - 1.13 03/31/26 - 1.08 Operating Margin 09/30/26 - - 06/30/26 - 57.57 03/31/26 - 50.94 Net Margin 09/30/26 - - 06/30/26 - 57.57 03/31/26 - 50.94 Pre-Tax Margin 09/30/26 - - 06/30/26 - 57.57 03/31/26 - 50.94 Book Value 09/30/26 - - 06/30/26 - 1.21 03/31/26 - 0.89 Inventory Turnover 09/30/26 - - 06/30/26 - 1.38 03/31/26 - 1.48 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©